AIM
AGIO icon

Allen Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Allen Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,781
Closed -$638K – 200
2025
Q1 		$638K Hold
21,781
– – 0.01% 150
2024
Q4 		$716K Hold
21,781
– – 0.01% 148
2024
Q3 		$968K Hold
21,781
– – 0.01% 146
2024
Q2 		$939K Sell
21,781
-21,790
-50% -$786K 0.01% 145
2024
Q1 		$1.27M Buy
43,571
+7,405
+20% +$198K 0.02% 124
2023
Q4 		$805K Buy
+36,166
New +$810K 0.01% 142

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return